Sinopharm Tech Holdings Limited reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was HKD 3.99 million compared to HKD 5.63 million a year ago. Net loss was HKD 2.34 million compared to net income of HKD 4.38 million a year ago.

Basic loss per share from continuing operations was HKD 0.0128 compared to basic earnings per share from continuing operations of HKD 0.0241 a year ago.